An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study

INTRODUCTION: A selective combination of C-reactive protein and albumin (termed the modified Glasgow Prognostic Score, mGPS) has been shown to have prognostic value, independent of tumour stage, in lung, gastrointestinal and renal cancers. It is also of interest that liver function tests such as bil...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Proctor, M J, Morrison, D S, Talwar, D, Balmer, S M, O'Reilly, D S J, Foulis, A K, Horgan, P G, McMillan, D C
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2011
Materias:
Molecular Diagnostics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3049591/
https://ncbi.nlm.nih.gov/pubmed/21266974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6606087
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares